James J.‐W. Duan

ORCID: 0000-0003-2730-9924
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cytokine Signaling Pathways and Interactions
  • Rheumatoid Arthritis Research and Therapies
  • Protease and Inhibitor Mechanisms
  • Synthesis and biological activity
  • Chemical Synthesis and Analysis
  • Psoriasis: Treatment and Pathogenesis
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Click Chemistry and Applications
  • Peptidase Inhibition and Analysis
  • Marine Sponges and Natural Products
  • Asymmetric Synthesis and Catalysis
  • Blood Coagulation and Thrombosis Mechanisms
  • Carbohydrate Chemistry and Synthesis
  • Traditional and Medicinal Uses of Annonaceae
  • Chemical Synthesis and Reactions
  • Oxidative Organic Chemistry Reactions
  • Cell Adhesion Molecules Research
  • Marine Toxins and Detection Methods
  • Synthetic Organic Chemistry Methods
  • Drug Transport and Resistance Mechanisms
  • Tuberculosis Research and Epidemiology
  • NF-κB Signaling Pathways
  • Protein Kinase Regulation and GTPase Signaling
  • Signaling Pathways in Disease

Bristol-Myers Squibb (United States)
2004-2020

Tianjin Medical University
2018

Bristol-Myers Squibb (Germany)
2002-2008

Experimental Station
1999-2003

Wilmington University
1999-2001

DuPont (United States)
1999-2000

University of Pennsylvania
1991-2000

Monell Chemical Senses Center
1991-1999

Philadelphia University
1993-1999

Harvard University
1993-1996

By addressing the relative stereochemistry of four acyclic portions via organic synthesis, complete maitotoxin (MTX) has been established as 1B. The C.1−C.15 portion was elucidated a two-phase approach:  (1) synthesis eight diastereomers possible for model C, representing C.1−C.11 portion, and D, C.11−C.15 comparison their proton carbon NMR characteristics with those MTX, concluding that 9 35 represent corresponding MTX; (2) two remote 51 52, represents MTX. C.35−C.39, C.63−C.68, C.134−C.142 ...

10.1021/ja961230+ article EN Journal of the American Chemical Society 1996-01-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTIodine monobromide (IBr) at low temperature: enhanced diastereoselectivity in electrophilic cyclizations of homoallylic carbonatesJames J. W. Duan and Amos B. Smith IIICite this: Org. Chem. 1993, 58, 14, 3703–3711Publication Date (Print):July 1, 1993Publication History Published online1 May 2002Published inissue 1 July 1993https://pubs.acs.org/doi/10.1021/jo00066a024https://doi.org/10.1021/jo00066a024research-articleACS PublicationsRequest reuse...

10.1021/jo00066a024 article EN The Journal of Organic Chemistry 1993-07-01

New γ-lactam TACE inhibitors were designed from known MMP inhibitors. A homology model of was built and examined to identify the S1' site as key area for selectivity over MMPs. Rational exploration P1'−S1' interactions resulted in discovery 3,5-disubstituted benzyl ether a TACE-selective P1' group. Further optimization led IK682 selective orally bioavailable inhibitor.

10.1021/jm0255670 article EN Journal of Medicinal Chemistry 2002-10-15

A new phenyl (3-phenylpyrrolidin-3-yl)sulfone series of RORγt inverse agonists was discovered utilizing the binding conformation previously reported bicyclic sulfonamide 1. Through a combination structure-based design and structure-activity relationship studies, polar set amides at N1-position pyrrolidine ring perfluoroisopropyl group para-position 3-phenyl were identified as critical structural elements to achieve high selectivity against PXR, LXRα, LXRβ. Further optimization led discovery...

10.1021/acsmedchemlett.9b00010 article EN ACS Medicinal Chemistry Letters 2019-02-26

Tumor necrosis factor alpha (TNFalpha) is an immunomodulatory and proinflammatory cytokine implicated in neuroinflammation neuronal damage response to cerebral ischemia. factor-alpha converting enzyme (TACE or ADAM17) a key sheddase that releases TNFalpha from its inactive cell-bound precursor. Using selective small molecule inhibitor of TACE, DPH-067517, we tested the hypothesis inhibition formation might have salutary effect ischemic stroke induced by embolic occlusion middle artery...

10.1124/mol.65.4.890 article EN Molecular Pharmacology 2004-03-25

Novel tricyclic analogues were designed, synthesized, and evaluated as RORγt inverse agonists. Several of these compounds potent in an IL-17 human whole blood assay exhibited excellent oral bioavailability mouse pharmacokinetic studies. This led to the identification compound 5, which displayed dose-dependent inhibition IL-17F production a IL-2/IL-23 stimulated pharmacodynamic model. In addition, 5 was studied acanthosis imiquimod-induced models skin inflammation, where it demonstrated...

10.1021/acsmedchemlett.0c00063 article EN ACS Medicinal Chemistry Letters 2020-03-31

RORγt is an important nuclear receptor that regulates the production of several pro-inflammatory cytokines such as IL-17 and IL-22. As a result, has been identified potential target for treatment various immunological disorders psoriasis, psoriatic arthritis, inflammatory bowel diseases. Structure computer-assisted drug design led to identification novel series tricyclic inverse agonists with significantly improved in vitro activity reporter (Gal4) human whole blood assays compared our...

10.1021/acs.jmedchem.9b01369 article EN Journal of Medicinal Chemistry 2019-10-22

Abstract Microhomology-mediated end joining (MMEJ) is a repair mechanism that resolves double strand DNA breaks. It considered secondary break behind homologous recombination (HR) but often utilized by tumors have lost the ability to perform HR. Critical this process polymerase theta (Pol θ). Pol θ heterobifunctional protein consists of an N-terminal helicase domain, disorder central region and C-terminal domain. Following resection MRE11-RAD50-NBS-1 (MRN) complex recruited site where it...

10.1158/1538-7445.am2025-4264 article EN Cancer Research 2025-04-21

To search for TNF-alpha (tumor necrosis factor alpha) converting enzyme (TACE) inhibitors, we designed a new class of macrocyclic hydroxamic acids by linking the P1 and P2' residues acyclic anti-succinate-based acids. A variety including amide, carbamate, alkyl, sulfonamido, Boc-amino, amino were found to be suitable P1-P2' linkers. With an N-methylamide at P3', 13-16-membered macrocycles prepared exhibited low micromolar activities in inhibition release from LPS-stimulated human whole...

10.1021/jm010127e article EN Journal of Medicinal Chemistry 2001-07-10

An asymmetric synthesis of the stereochemically fully endowed C(9−25) spiroketal fragment (+)-BC calyculins (1−8) is described. Highlights include: a highly diastereoselective IBr-induced iodocarbonate cyclization to introduce C(21) stereocenter in epoxide (+)-18, unions exploiting reaction acyl anion equivalents with epoxides construct masked advanced aldols (−)-35 and (+)-71 as single diastereomers, chelation-controlled addition C(14−15) vinyl group aldehyde (+)-38 set stereogenicity at...

10.1021/ja992134m article EN Journal of the American Chemical Society 1999-10-30

Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alpha (TNFα). Structure–activity relationships in both the quinoline naphthyridine series leading identification compound 42 with excellent potency pharmacokinetic profile are discussed. X-ray co-crystal structure analysis ultracentrifugation experiments clearly demonstrate that these distort TNFα trimer...

10.1021/acs.jmedchem.0c01732 article EN Journal of Medicinal Chemistry 2020-12-01

A convergent total synthesis leading to (+)-calyculin and (−)-calyculin B (1 2), antipodes of the potent, highly selective remarkably cell-permeable phosphatase inhibitors calyculins B, has been achieved. In preceding paper we outlined asymmetric C(9−25) spiroketal dipropionate subunit (+)-BC; herein describe construction C(1−8) cyanotetraene, an C(26−37) oxazole, fragment assembly final elaboration (+)-1 (−)-2. Highlights include: application a one-pot three-component Suzuki reaction for...

10.1021/ja992135e article EN Journal of the American Chemical Society 1999-10-30

Elevated levels of tumor necrosis factor-alpha (TNF-alpha) have been associated with several inflammatory diseases, and therefore, strategies for its suppression become important targets in drug discovery. Our efforts to suppress TNF-alpha centered on the inhibition converting enzyme (TACE) through use hydroxamate inhibitors. Starting from broad-spectrum matrix metalloproteinase (MMP) inhibitors, we designed synthesized novel benzothiadiazepines as potent selective TACE The were variation P1...

10.1021/jm020475w article EN Journal of Medicinal Chemistry 2003-04-02

DPC 333 ((2<i>R</i>)-2-((3<i>R</i>)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-<i>N</i>-hydroxy-4-methylpentanamide)) is a potent and selective inhibitor of tumor necrosis factor (TNF)-α-converting enzyme (TACE). It significantly inhibits lipopolysaccharide-induced soluble TNF-α production in blood from rodents, chimpanzee, human, with IC<sub>50</sub> values ranging 17 to 100 nM. In rodent models endotoxemia, inhibited the dose-dependent manner, an oral...

10.1124/dmd.107.015933 article EN Drug Metabolism and Disposition 2007-07-26

purpose. The efficacy of three matrix metalloproteinase (MMP) inhibitors with various selectivities (Ro-31-9790, AG3340, and DPC-A37668) was investigated in a rat model retinopathy prematurity, to examine the roles MMP-2 -9 retinal neovascularization. susceptibilities MMP-2−/− -9−/− mice preretinal neovascularization were mouse oxygen-induced retinopathy. methods. Sprague-Dawley newborn rats exposed alternating episodes 50% 10% oxygen (variable exposure) induce Three MMP selectivity profiles...

10.1167/iovs.06-0082 article EN Investigative Ophthalmology & Visual Science 2007-01-25
Coming Soon ...